-- 周四，多伦多证券交易所再次跌入下跌区间，基本金属和能源板块双双走低。此前有报道称，伊朗仍在审查美国提出的和平方案，而美伊两国仍在就结束战争的谈判进行磋商。 S&P/TSX综合指数收跌125.2点，报33,856.62点。基本金属板块下跌1.7%，能源板块下跌1.4%，领跌各板块。相比之下，电池金属指数领涨，上涨7.8%。 受整体市场低迷情绪的影响，金融板块下跌0.4%。尽管罗森伯格研究公司发布了一份题为《加拿大银行：优质股，高价位》的报告，指出长期市场趋势继续支撑加拿大银行的溢价估值，因为全球对非美元、大宗商品经济体的兴趣日益浓厚，银行业从中受益。 罗森伯格高级市场策略师梅赫迈特·贝塞伦 (Mehmet Beceren) 撰写的这份报告指出，加拿大银行业受益的不仅仅是银行业的基本面。贝塞伦表示，作为加拿大股指的权重股，随着投资者寻求投资硬资产、大宗商品、石油、黄金和非美元市场，全球资金流入加拿大，加拿大六大银行也从中获益。 另一个要点是，质量溢价是合理的。贝塞伦补充道：“相对于历史水平，目前的估值并不便宜，但高盈利能力和有利的主题因素足以支撑更高的市盈率，尤其是在市场持续重新评估优质盈利能力的情况下。” 大宗商品方面，西德克萨斯中质原油连续第三个交易日下跌，但由于美伊和平协议前景不明朗，价格从当日低点反弹。6月交割的西德克萨斯中质原油期货收盘下跌0.27美元，报每桶94.81美元，此前一度触及每桶89.85美元。 7月布伦特原油期货价格下跌0.67美元，至每桶100.60美元。 周四下午，由于市场乐观预期结束伊朗战争的协议可能即将达成，黄金价格连续第三个交易日上涨，这打压了油价，并导致美元走低。此前，市场对战争引发的供应冲击将推高通胀并迫使利率上升的担忧有所缓解。6月交割的黄金期货价格上涨20.60美元，至每盎司4714.00美元，此前周三已上涨125.80美元。
Related Articles
Research
Research Alert: Callaway Golf Beats Estimates; Raises Guidance
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Callaway Golf delivered strong Q1 2026 results with net sales of $687.5M (+9.2%) and adjusted EBITDA of $163.7M (+31.1%), demonstrating early benefits from the Topgolf divestiture. Both segments performed well, with Golf Equipment sales growing 9.5% to $486.2M and Apparel increasing 8.4% to $201.3M, while GAAP gross margin expanded 250 bps to 47.5%. The balance sheet transformation is evident with $500M cash against $474M debt, enabling $79M in share repurchases and aggressive capital returns following the strategic divestiture. Management raised full-year 2026 guidance with net sales now expected at $2.015B-$2.070B and adjusted EBITDA at $211M-$233M, reflecting confidence in sustained demand and operational improvements. We are impressed with the company's quick success as a focused entity. However, valuation appears stretched at over 23x consensus 2026 EBITDA estimates even if estimates rise to match the company's guidance.
$CALY
Research
Research Alert: Gmed Posts Strong Q1 On Strong Sales, Margin Expansion, And Nevro Integration
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:GMED delivered exceptional Q1 2026 results, with adjusted EPS of $1.12 (+64.7% Y/Y), significantly exceeding expectations, while net sales reached $759.9M (+27.0% Y/Y). The base business excluding Nevro grew a solid 13.2% Y/Y to $677.2M, indicating healthy organic growth across the portfolio. The standout performance was attributed to remarkable margin expansion, with adjusted EBITDA margins improving 260 bps to 32.3% and gross margins expanding 280 bps to 66.4% as the company continued realizing meaningful synergies from its NuVasive and Nevro acquisitions. Management raised 2026 adjusted EPS guidance to $4.70-$4.80 from the previous $4.40-$4.50 range while reaffirming revenue guidance of $3.18B-$3.22B, reflecting confidence in operational leverage benefits. The core spine business showed particular strength, with US Spine delivering its third consecutive quarter of over 10% growth, while Nevro integration progressed in line with expectations, contributing $82.7M in sales during the quarter.
$GMED
Mining & Metals
Earnings Flash (VHI.TO) VitalHub Reports Q1 Total Revenue up 47% YoY to $31.9M
$VHI.TO